Sinphar Pharmaceutical Co (TPE:1734) Cyclically Adjusted Book per Share: NT$16.85 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1734 Sinphar Pharmaceutical Co Ltd TPE:1734
82 GF Score
Price NT$30.75
GF Value NT$29.90
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Sinphar Pharmaceutical Co Cyclically Adjusted Book per Share?

Sinphar Pharmaceutical Co TPE:1734 82 Cyclically Adjusted Book per Share is NT$16.85 as of Jun. 2026. GuruFocus rates TPE:1734 with a GF Score™ of 82/100 and a GF Value™ of NT$29.90 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Sinphar Pharmaceutical Co's adjusted book value per share for the three months ended in Jun. 2026 was NT$16.140. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$16.85 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Sinphar Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 0.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Sinphar Pharmaceutical Co was 4.30% per year. The lowest was 0.30% per year. And the median was 3.15% per year.

As of today (2026-08-31), Sinphar Pharmaceutical Co's current stock price is NT$30.75. Sinphar Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was NT$16.85. Sinphar Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.82.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sinphar Pharmaceutical Co was 3.60. The lowest was 0.81. And the median was 1.59.


Sinphar Pharmaceutical Co  (TPE:1734) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sinphar Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=30.75/16.85
=1.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sinphar Pharmaceutical Co was 3.60. The lowest was 0.81. And the median was 1.59.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Sinphar Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Sinphar Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Sinphar Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinphar Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Sinphar Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.56 16.38 16.56 16.60 16.55

Sinphar Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.70 16.70 16.55 16.76 16.85

TPE:1734 vs VRTX, REGN, MRNA: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Sinphar Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinphar Pharmaceutical Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinphar Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sinphar Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


TPE:1734
82GF Score
Sinphar Pharmaceutical Co Ltd TPE:1734
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sinphar Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sinphar Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=16.14/333.9520*333.9520
=16.140

Current CPI (Jun. 2026) = 333.9520.

Sinphar Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 14.390 241.428 19.905
201612 14.467 241.432 20.011
201703 14.248 243.801 19.517
201706 14.212 244.955 19.376
201709 14.362 246.819 19.432
201712 14.388 246.524 19.491
201803 14.470 249.554 19.364
201806 14.215 251.989 18.839
201809 13.735 252.439 18.170
201812 13.692 251.233 18.200
201903 13.821 254.202 18.157
201906 13.568 256.143 17.690
201909 12.951 256.759 16.845
201912 13.023 256.974 16.924
202003 13.112 258.115 16.964
202006 12.488 257.797 16.177
202009 12.625 260.280 16.198
202012 12.842 260.474 16.465
202103 12.463 264.877 15.713
202106 12.901 271.696 15.857
202109 12.781 274.310 15.560
202112 12.738 278.802 15.258
202203 13.145 287.504 15.269
202206 13.322 296.311 15.014
202209 13.665 296.808 15.375
202212 13.712 296.797 15.429
202303 14.099 301.836 15.599
202306 13.714 305.109 15.010
202309 14.165 307.789 15.369
202312 14.498 306.746 15.784
202403 15.084 312.332 16.128
202406 14.606 314.175 15.525
202409 14.883 315.301 15.763
202412 15.270 315.605 16.158
202503 15.856 319.799 16.558
202506 14.967 322.561 15.496
202509 15.480 324.800 15.916
202512 16.115 324.054 16.607
202603 16.552 330.213 16.739
202606 16.140 333.952 16.140

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$16.85 mean?
Sinphar Pharmaceutical Co (TPE:1734) has a Cyclically Adjusted Book per Share of NT$16.85 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sinphar Pharmaceutical Co and its competitors.
Is Sinphar Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Sinphar Pharmaceutical Co's current Cyclically Adjusted Book per Share is NT$16.85. Overall, Sinphar Pharmaceutical Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sinphar Pharmaceutical Co's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Sinphar Pharmaceutical Co's Cyclically Adjusted Book per Share of NT$16.85 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sinphar Pharmaceutical Co and its competitors. Sinphar Pharmaceutical Co's current Cyclically Adjusted Book per Share is NT$16.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinphar Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Sinphar Pharmaceutical Co (TPE:1734) is currently considered Fairly Valued. The stock's GF Value™ is NT$29.90, compared to a current price of NT$30.75 — trading 2.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is NT$16.85. Sinphar Pharmaceutical Co's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Sinphar Pharmaceutical Co (TPE:1734), the current Cyclically Adjusted Book per Share is NT$16.85 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sinphar Pharmaceutical Co (TPE:1734) Overvalued in 2026?

Based on GuruFocus' analysis, Sinphar Pharmaceutical Co stock appears to be overvalued. The current stock price of NT$30.75 is trading 2.8% above its estimated GF Value™ of NT$29.90. GuruFocus considers Sinphar Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TPE:1734:

  • Cyclically Adjusted Book per Share: NT$16.85
  • GF Value™: NT$29.90 vs. price of NT$30.75 (2.8% above fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the TPE:1734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sinphar Pharmaceutical Co Business Description

Address No.84, Zhongshan Road, Dongshan Township, Zhongshan Village, Yilan, TWN, 269
Sinphar Pharmaceutical Co Ltd operates in the pharmaceutical segment. The company mainly engages in the production, processing, and trading of various Chinese medicines, medicinal cosmetics, and nutrients. The company's reportable segments are; Pharmaceuticals which derives key revenue, Healthy food, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from China, Vietnam, Indonesia, America, and other regions.
82GF Score

Get the complete analysis for TPE:1734

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$30.75
Price
NT$29.90
GF Value